--Seasoned medical technology leader tapped to maximize momentum in APAC

Cordis, a global leader in cardiovascular technologies, today announced that 
Bryan Loo will assume the role of President of the Asia-Pacific (APAC) region 
effective July 18, 2022. Loo will head a leadership team responsible for 
commercial and clinical strategy, business operations, and teammate development 
in the company's fast-growing APAC region.

Photo - https://mma.prnewswire.com/media/1852408/Cordis_Bryan_Loo.jpg
Logo - https://mma.prnewswire.com/media/1676076/Cordis_Logo.jpg 

"We are pleased to welcome Bryan to the team," said Cordis CEO Shar Matin. "He 
brings a depth of leadership and customer relationship-building experience in 
the APAC medical technology and healthcare markets that spans decades. He has a 
reputation for relentless execution and growing high-performing teams that 
produce results for the business and build strong relationships with physician 
customers."

Loo joins Cordis from Genesis Medtech, where he served as President and built 
the infrastructure for its vertically integrated, open-platform model. During 
his tenure at Asia Pacific Danaher Dental as President and Bayer Radiology as 
APAC Vice-President, he built a reputation for pivoting businesses to 
double-digit growth. He also previously held multiple roles at Cordis over a 
16-year period, when it was a part of J&J Medical, including Vice President of 
Cordis China, delivering the largest revenue and highest profit in the division.

"I am honored to rejoin this new, reenergized Cordis team," said Loo. "Its 
legacy of providing trusted, differentiated solutions that improve patients' 
lives is unmatched, and now I see a compelling opportunity to participate in a 
new era of innovation and transformation that is possible as an independent 
Cordis."

According to Matin, Loo will leverage his deep roots in Asia to grow customer 
relationships and attract top talent that aligns with his vision for symbiotic 
teams that are inspired by the pioneering spirit that built Cordis over the 
past 60 years and is being rediscovered today.

Loo will be based in Singapore. He is a Business graduate of Nanyang 
Technological University and benefitted from executive leadership programs in 
Harvard Business School and INSEAD.

About Cordis

Cordis is a worldwide leader in the development and manufacturing of 
interventional vascular technology with a more than 60-year history of 
pioneering breakthrough cardiovascular technologies to treat millions of 
patients. With a reputation for clinical acumen, training, and services, Cordis 
established a legacy of innovation in high-quality and less-invasive 
cardiovascular products and built a strong global footprint with operations in 
more than 70 countries around the world.

Media contact:

Margaret-Sarah Alexander
Vice President, Head of Global Strategic Marketing
margaretsarah.alexander@cordis.com
m. +1 203-297-4182

SOURCE: Cordis